2011 News Releases

2011 News Releases

CSL Behring Awards Lead Grant to Patient Organizations to Educate Constituents on State Insurance Exchanges

CSL Behring announced today that it has awarded a $40,000 advocacy grant to the Ameri…

02 Dec 2011

Study Shows Efficacy of C1-Esterase Inhibitor Concentrate in Treating Acute Attacks of Hereditary Angioedema in Children and Adolescents

New findings demonstrate that treatment with C1-esterase inhibitor (C1-INH) concentra…

05 Nov 2011

Study Shows C1-Esterase Inhibitor Concentrate Is Safe and Consistently Effective for Long-Term Treatment of Hereditary Angioedema Attacks at Any Body Location

C1-esterase inhibitor (C1-INH) concentrate at 20 U/kg is a safe and effective therapy…

05 Nov 2011

National Jewish Health Names Recipient of The CSL Behring – National Jewish Health Fellowship in Immunology

National Jewish Health (NJH) announced that Jordan Abbott, M.D., is the recipient of …

04 Nov 2011

CSL Behring Named Life Sciences Company Of The Year By Philadelphia Business Journal and Pennsylvania Bio

CSL Behring, a global biotherapeutics company specializing in plasma-derived and reco…

06 Oct 2011

Young People With Rare Medical Conditions Faced With Care Issues and Possible Healthcare Cuts Make Their Voices Heard

Young people between the ages of 15 and 22 converged on Washington, D.C. this summer,…

29 Sep 2011